ASEAN NOW - Icon Group

Transcript

Mark Middleton:

I’m Mark Middleton. I’m the CEO of the Icon Group. We are now Australia’s largest provider of cancer care.

We’re a truly integrated provider of cancer care in that we provide pharmacy services, oncology compounding, medical oncology and radiation oncology.

We have a very, very large presence now across Australia. We are also in New Zealand and Singapore and growing rapidly into the ASEAN market.

Well the ASEAN market is very important to us because, number one, it’s right on our doorstep. Number two, Australian healthcare is very well respected in this region. We have exceptionally trained healthcare professionals.

But we certainly understand that if we’re going to continue to grow and continue to help people we need to invest heavily in these markets and that’s exactly what we’re doing.

We’re already very, very active in Singapore. We have now owned our own cancer care business in Singapore for the last 18 months. It continues to grow and go strength to strength. We have terrific doctors, we have wonderful staff and we have wonderful leadership.

And, really, we wanted to establish ourselves in Singapore to give us a regional hub, a regional headquarters that would allows us to continue to grow through that region and to provide services across that ASEAN market.

Well the ASEAN market is important to us because they are facing a significant cancer burden. There is a lack of highly trained clinicians and specialists to deliver cancer care.

So for Icon’s two and a half thousand people, we have a very, very clear mission. That is to deliver the best care possible to as many people as possible as close to home as possible.

[END TRANSCRIPT]